Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
SHIRE
(LSS:
SHP
)
20.95
GBP
UNCHANGED
Streaming Delayed Price
/ Updated:
11:36 AM EDT, Jun 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
911,510
Open
20.90
Bid (Size)
20.94 (0)
Ask (Size)
20.96 (0)
Prev. Close
20.95
Today's Range
20.86 - 21.10
52wk Range
16.82 - 22.35
Shares Outstanding
553,706,302
Dividend Yield
0.53%
Top News
More News
Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases
May 20, 2013
Production of Therapeutically Relevant Levels of Clotting Factor VIII Further Demonstrates Breadth and Leverage of this Novel Approach to Monogenic Diseases
Read More
from
PR Newswire
Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
May 17, 2013
from
PR Newswire
More News
Read More
Shire Wins Patent Trial Against Watson Concerning LIALDA®
May 09, 2013
from
PR Newswire
Acceleron and Shire Conclude Collaboration on ACE-031
May 02, 2013
from
Business Wire News Releases
New Chief Executive Reports Q1 Results and Sets out Strategy for Growth
May 02, 2013
from
PR Newswire
Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adolescents with ADHD
May 01, 2013
from
PR Newswire
Shire Settles All Pending Litigation with Actavis and Watson Concerning INTUNIV®
April 25, 2013
from
PR Newswire
Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare Diseases
April 09, 2013
from
PR Newswire
Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
March 25, 2013
from
PR Newswire
Shire Acquires Premacure AB
March 12, 2013
from
PR Newswire
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.